1. Home
  2. EPIX vs KUKE Comparison

EPIX vs KUKE Comparison

Compare EPIX & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • KUKE
  • Stock Information
  • Founded
  • EPIX 2009
  • KUKE 2002
  • Country
  • EPIX Canada
  • KUKE China
  • Employees
  • EPIX N/A
  • KUKE N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • EPIX Health Care
  • KUKE Real Estate
  • Exchange
  • EPIX Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • EPIX 75.9M
  • KUKE 86.8M
  • IPO Year
  • EPIX N/A
  • KUKE 2021
  • Fundamental
  • Price
  • EPIX $1.87
  • KUKE $2.54
  • Analyst Decision
  • EPIX Hold
  • KUKE
  • Analyst Count
  • EPIX 3
  • KUKE 0
  • Target Price
  • EPIX $2.00
  • KUKE N/A
  • AVG Volume (30 Days)
  • EPIX 452.3K
  • KUKE 9.3K
  • Earning Date
  • EPIX 08-04-2025
  • KUKE 08-05-2025
  • Dividend Yield
  • EPIX N/A
  • KUKE N/A
  • EPS Growth
  • EPIX N/A
  • KUKE N/A
  • EPS
  • EPIX N/A
  • KUKE N/A
  • Revenue
  • EPIX N/A
  • KUKE $9,442,397.00
  • Revenue This Year
  • EPIX N/A
  • KUKE N/A
  • Revenue Next Year
  • EPIX N/A
  • KUKE N/A
  • P/E Ratio
  • EPIX N/A
  • KUKE N/A
  • Revenue Growth
  • EPIX N/A
  • KUKE N/A
  • 52 Week Low
  • EPIX $1.40
  • KUKE $1.45
  • 52 Week High
  • EPIX $7.88
  • KUKE $17.50
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 63.77
  • KUKE 26.20
  • Support Level
  • EPIX $1.86
  • KUKE $2.58
  • Resistance Level
  • EPIX $1.88
  • KUKE $2.73
  • Average True Range (ATR)
  • EPIX 0.02
  • KUKE 0.12
  • MACD
  • EPIX 0.00
  • KUKE -0.03
  • Stochastic Oscillator
  • EPIX 94.74
  • KUKE 8.33

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: